Comerica Securities Increased Merck & Co (MRK) Stake; Northern Trust Trimmed Marsh & Mclennan Cos (MMC) Position By $8.99 Million

May 24, 2018 - By Clifton Ray

Marsh & McLennan Companies, Inc. (NYSE:MMC) Logo

Northern Trust Corp decreased Marsh & Mclennan Cos Inc (MMC) stake by 1.63% reported in 2017Q4 SEC filing. Northern Trust Corp sold 111,008 shares as Marsh & Mclennan Cos Inc (MMC)’s stock rose 0.87%. The Northern Trust Corp holds 6.70 million shares with $545.65M value, down from 6.82M last quarter. Marsh & Mclennan Cos Inc now has $41.25 billion valuation. The stock decreased 0.42% or $0.34 during the last trading session, reaching $81.3. About 487,037 shares traded. Marsh & McLennan Companies, Inc. (NYSE:MMC) has risen 9.09% since May 24, 2017 and is uptrending. It has underperformed by 2.46% the S&P500.

Comerica Securities Inc increased Merck & Co Inc (MRK) stake by 15.95% reported in 2017Q4 SEC filing. Comerica Securities Inc acquired 9,752 shares as Merck & Co Inc (MRK)’s stock declined 4.63%. The Comerica Securities Inc holds 70,902 shares with $4.02M value, up from 61,150 last quarter. Merck & Co Inc now has $159.05 billion valuation. The stock decreased 0.08% or $0.05 during the last trading session, reaching $59.12. About 3.81M shares traded. Merck & Co., Inc. (NYSE:MRK) has declined 14.94% since May 24, 2017 and is downtrending. It has underperformed by 26.49% the S&P500.

Among 15 analysts covering Marsh & McLennan (NYSE:MMC), 8 have Buy rating, 0 Sell and 7 Hold. Therefore 53% are positive. Marsh & McLennan had 38 analyst reports since September 8, 2015 according to SRatingsIntel. Keefe Bruyette & Woods maintained Marsh & McLennan Companies, Inc. (NYSE:MMC) rating on Friday, October 27. Keefe Bruyette & Woods has “Buy” rating and $88.0 target. The stock of Marsh & McLennan Companies, Inc. (NYSE:MMC) earned “Buy” rating by Wells Fargo on Thursday, July 27. The rating was maintained by Citigroup on Thursday, July 13 with “Buy”. The firm has “Hold” rating given on Monday, February 5 by Jefferies. Jefferies maintained the stock with “Hold” rating in Friday, June 16 report. The firm has “Hold” rating given on Tuesday, September 5 by Jefferies. The stock of Marsh & McLennan Companies, Inc. (NYSE:MMC) has “Buy” rating given on Thursday, December 21 by Keefe Bruyette & Woods. The rating was downgraded by Credit Suisse on Monday, January 11 to “Neutral”. The stock of Marsh & McLennan Companies, Inc. (NYSE:MMC) earned “Buy” rating by Citigroup on Friday, February 9. Bank of America upgraded the stock to “Buy” rating in Friday, January 27 report.

Investors sentiment increased to 1.05 in 2017 Q4. Its up 0.10, from 0.95 in 2017Q3. It increased, as 34 investors sold MMC shares while 229 reduced holdings. 83 funds opened positions while 194 raised stakes. 419.18 million shares or 1.51% less from 425.59 million shares in 2017Q3 were reported. First Amer Bancorp owns 48,307 shares or 0.3% of their US portfolio. Pictet Asset Management Ltd holds 0.1% of its portfolio in Marsh & McLennan Companies, Inc. (NYSE:MMC) for 462,002 shares. Hartford Invest Mngmt has invested 0.25% in Marsh & McLennan Companies, Inc. (NYSE:MMC). Lau Assocs Limited Liability Corporation owns 3,159 shares. Lodestar Counsel Il reported 2,684 shares stake. First Personal Financial reported 4,194 shares stake. Mutual Of America Mgmt Limited Liability Company owns 64,947 shares for 0.08% of their portfolio. Tiverton Asset Limited Liability Corporation reported 4,947 shares or 0.03% of all its holdings. Abner Herrman & Brock Limited Liability accumulated 0.04% or 2,699 shares. Nuveen Asset Mngmt Ltd stated it has 0.02% in Marsh & McLennan Companies, Inc. (NYSE:MMC). South Dakota Investment Council reported 35,800 shares. 138,439 are held by Badgley Phelps Bell Inc. Regentatlantic Cap Limited Liability Com owns 16,120 shares. Willingdon Wealth Mgmt reported 1,040 shares stake. Gabelli Funds Ltd Llc holds 0.25% or 528,000 shares in its portfolio.

Northern Trust Corp increased Workday Inc (NYSE:WDAY) stake by 49,396 shares to 900,940 valued at $91.66M in 2017Q4. It also upped Ralph Lauren Corp (NYSE:RL) stake by 4,149 shares and now owns 698,183 shares. Alibaba Group Hldg Ltd (NYSE:BABA) was raised too.

More important recent Marsh & McLennan Companies, Inc. (NYSE:MMC) news were published by: Twst.com which released: “MMC – Marsh & McLennan Companies Inc.: Marsh & McLennan Companies Holds 2018 Stockholders’ Meeting” on May 17, 2018, also Seekingalpha.com published article titled: “Marsh & McLennan Cos. (MMC) Q1 2018 Results – Earnings Call Transcript”, Twst.com published: “MMC – Marsh & McLennan Companies Inc.: Marsh & McLennan Companies to Webcast 2018 Annual Meeting of …” on May 14, 2018. More interesting news about Marsh & McLennan Companies, Inc. (NYSE:MMC) was released by: Globenewswire.com and their article: “Investor Expectations to Drive Momentum within SUPERVALU INC, Dunkin’ Brands Group, Marsh & McLennan …” with publication date: May 11, 2018.

Since December 18, 2017, it had 0 insider buys, and 9 selling transactions for $65.25 million activity. Portalatin Julio A sold $893,273 worth of stock or 10,911 shares. On Monday, March 5 Glaser Daniel S sold $3.40 million worth of Marsh & McLennan Companies, Inc. (NYSE:MMC) or 41,504 shares. McDonald Scott had sold 11,418 shares worth $968,940. Beshar Peter J sold $863,821 worth of Marsh & McLennan Companies, Inc. (NYSE:MMC) on Monday, March 5. $1.88M worth of Marsh & McLennan Companies, Inc. (NYSE:MMC) was sold by MCGIVNEY MARK C on Monday, February 26. Mills Stacy sold 1,145 shares worth $94,972. $4.29 million worth of Marsh & McLennan Companies, Inc. (NYSE:MMC) shares were sold by Gilbert E Scott.

Analysts await Marsh & McLennan Companies, Inc. (NYSE:MMC) to report earnings on July, 26. They expect $1.11 earnings per share, up 11.00% or $0.11 from last year’s $1 per share. MMC’s profit will be $563.19 million for 18.31 P/E if the $1.11 EPS becomes a reality. After $1.38 actual earnings per share reported by Marsh & McLennan Companies, Inc. for the previous quarter, Wall Street now forecasts -19.57% negative EPS growth.

Investors sentiment decreased to 0.94 in Q4 2017. Its down 0.12, from 1.06 in 2017Q3. It fall, as 94 investors sold MRK shares while 631 reduced holdings. 123 funds opened positions while 558 raised stakes. 1.93 billion shares or 1.34% less from 1.96 billion shares in 2017Q3 were reported. Cypress Grp has 0.54% invested in Merck & Co., Inc. (NYSE:MRK). Calamos Advisors Llc reported 952,921 shares or 0.27% of all its holdings. Thomas J Herzfeld Advsr Inc reported 2,439 shares stake. Modera Wealth Ltd Company invested in 20,857 shares. Horizon Kinetics Ltd Liability Com reported 47,550 shares. Roosevelt Invest Inc has invested 0.02% in Merck & Co., Inc. (NYSE:MRK). Bartlett & Communications Limited Company, a Ohio-based fund reported 79,324 shares. Wafra Advisory Group Inc New York holds 496,337 shares or 1.27% of its portfolio. Burns J W & Com Incorporated has 7,725 shares. North Star Invest Management Corporation has invested 0.34% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Thompson Siegel And Walmsley Limited Co owns 0.08% invested in Merck & Co., Inc. (NYSE:MRK) for 112,297 shares. Geode Capital Mgmt Llc holds 0.56% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 29.12M shares. Legacy Private Tru has 0.04% invested in Merck & Co., Inc. (NYSE:MRK). Westpac Bk Corporation holds 0.34% or 262,368 shares in its portfolio. Fukoku Mutual Life Insurance has invested 1.1% in Merck & Co., Inc. (NYSE:MRK).

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 21 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. Merck & Co. Inc. had 90 analyst reports since August 13, 2015 according to SRatingsIntel. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Outperform” rating by Credit Suisse on Wednesday, February 14. UBS maintained Merck & Co., Inc. (NYSE:MRK) rating on Friday, August 19. UBS has “Buy” rating and $70 target. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Equal-Weight” rating by Morgan Stanley on Monday, October 30. The company was maintained on Friday, April 15 by Jefferies. BMO Capital Markets maintained Merck & Co., Inc. (NYSE:MRK) on Tuesday, June 6 with “Buy” rating. The stock of Merck & Co., Inc. (NYSE:MRK) has “Underperform” rating given on Monday, December 19 by Jefferies. The stock has “Buy” rating by Citigroup on Monday, October 30. The firm has “Sell” rating by Jefferies given on Monday, July 17. Credit Suisse maintained the stock with “Outperform” rating in Monday, February 5 report. The rating was downgraded by Barclays Capital to “Equal-Weight” on Monday, October 30.

Comerica Securities Inc decreased Voya Prime Rate Tr (NYSE:PPR) stake by 151,391 shares to 174,577 valued at $889,000 in 2017Q4. It also reduced Regal Entmt Group (NYSE:RGC) stake by 108,107 shares and now owns 74,690 shares. Ishares Tr (IVW) was reduced too.

More notable recent Merck & Co., Inc. (NYSE:MRK) news were published by: Streetinsider.com which released: “Foundation Medicine (FMI) Reports Immuno-Oncology Companion Diagnostics Collaboration with Merck (MRK)” on May 24, 2018, also Bizjournals.com with their article: “By Ron Leuty – Reporter, San Francisco Business Times” published on May 23, 2018, 247Wallst.com published: “What to Look For in the Merck and Pfizer Reports Tuesday Morning” on April 30, 2018. More interesting news about Merck & Co., Inc. (NYSE:MRK) were released by: Livetradingnews.com and their article: “Merck & Co., Inc. (NYSE:MRK) Trending Upwards” published on May 18, 2018 as well as Seekingalpha.com‘s news article titled: “New Ebola outbreak hits Congo” with publication date: May 13, 2018.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>